Pre-clinical research from a top preclinical Contract Research Organization in Kiev, Ukraine.
We are an independent Contract Research Organization based in the United States that provides pre-clinical drug services in top-notch, GLP-certified testing sites in Kiev, Ukraine. Our testing facilities are supported by the Ukrainian National Academy of Medical Sciences and Health Department and provide support for commercial development of new medicine discoveries as part of their main purpose. Our company was created to provide the high quality, low-cost services of these laboratories to start-up biotech companies in the U.S. and EU, thereby offering a smart option for advancing development programs quickly and at much lower cost than other commercial CROs. We offer a wide range of preclinical toxicology including drug safety, acute and chronic toxicity, pharmacological screening, bio-availability , bio-equivalence , and complete in vitro and in vivo screening for anticancer activity.
Our preclinical CRO is able to price pre-clinical research far below other Contract Research Organizations since we have a very low overhead in the U.S. and conduct all trials in Ukraine where labor and facility costs are much lower. Our staff in the U.S. is comprised of only of the organization principals who work directly with customers; we don’t have any marketing expenses other than our website, and no head offices, supporting staff or other overhead to inflate prices. We have much lower trials conduct costs in Kiev due to much lower personnel rates and are happy to offer our most attractive rates for long-term and more complex preclinical trials where labor is the most significant portion of the overall cost. Because we use the same reliable international providers for animal models, reagents and laboratory materials as other CROs, we don’t have any cost advantage on these items and so less overall cost savings for very short-term pre-clinical tests. But, regardless of your trial protocol and duration, our goal is to give our clients the best possible value for their investment.